Skip to main content
. Author manuscript; available in PMC: 2019 Jun 21.
Published in final edited form as: Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8

Figure 1.

Figure 1.

Mechanisms associated with variable prognosis and risk of CNS recurrence in extranodal DLBCL of different anatomical origin.

ABC: activated B-cell subtype; CNS: central nervous system; DLBCL: diffuse large B-cell lymphoma; GCB: germinal center B-cell subtype; HGBCL: high-grade B-cell lymphoma